Betaxolol EP Impurity E
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1329613-85-5Betaxolol EP Impurity E

● In Stock

Catalogue No.:VL2940004
CAS No.:1329613-85-5
Mol. Formula:C18H32ClNO3
Mol. Weight:345.9 g/mol

Additional information on CAS 1329613-85-5

Parent drug

Betaxolol

IUPAC Name

(2RS)-1-[4-(2-Butoxyethyl)phenoxy]-3-[(1-methylethyl)-amino]propan-2-ol hydrochloride

Pharmacopoeial Synonyms

Betaxolol Open Chain Analog (HCl Salt)

Other Synonyms

O-Des(cyclopropylmethyl)-O-butyl Betaxolol Hydrochloride ; 1-(4-(2-Butoxyethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol Hydrochloride

Smile

OC(CNC(C)C)COC1=CC=C(CCOCCCC)C=C1.Cl

InChI

InChI=1S/C18H31NO3.ClH/c1-4-5-11-21-12-10-16-6-8-18(9-7-16)22-14-17(20)13-19-15(2)3;/h6-9,15,17,19-20H,4-5,10-14H2,1-3H3;1H

Description

Betaxolol EP Impurity E (HCl Salt), also known as Betaxolol Open Chain Analog (HCl Salt), in various pharmacopoeias, is a highly characterized standard. It meets strict regulatory requirements set by USP, EMA, JP, and BP, making it a crucial component in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Betaxolol. To ensure precision and reliability in analytical applications, this impurity standard is supplied with a detailed Structure Elucidation Report (SER), offering valuable insights for method development and quality control.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url